Pinnacle Wealth Management Advisory Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Pinnacle Wealth Management Advisory Group's REGN Position: Q2 2026 in Review

Pinnacle Wealth Management Advisory Group increased its Regeneron Pharmaceuticals (REGN) stake by 12% in Q2 2026, buying an estimated $203K and bringing the position to 2,713 shares worth $1.69M. The position accounts for 0.1% of the portfolio, ranked #142.

Pinnacle Wealth Management Advisory Group first reported a position in REGN in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.87M in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

• Pinnacle Wealth Management Advisory Group held 2,713 shares of Regeneron Pharmaceuticals worth $1.69M as of Q2 2026.
• Pinnacle Wealth Management Advisory Group bought 298 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $203K.
• Regeneron Pharmaceuticals made up 0.1% of Pinnacle Wealth Management Advisory Group's portfolio in Q2 2026, its #142 holding.
• Pinnacle Wealth Management Advisory Group first reported a position in Regeneron Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
• Pinnacle Wealth Management Advisory Group's Regeneron Pharmaceuticals position peaked at $1.87M in Q1 2026.
• 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q2 2026, filed 5 Aug 2026.